Know Cancer

or
forgot password
  • cancer clinical trials in gainesville, GA

  • Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Metastatic Melanoma
    Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Lymphoma
    Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Metastatic Breast Cancer
    Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Non-Small-Cell Lung Cancer
    Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Anaplastic Carcinoma of the Gallbladder, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Breast Cancer
    Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Colorectal Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Head and Neck Cancer, Precancerous Condition
    Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    S0820, Adenoma and Second Primary Prevention Trial
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Colorectal Neoplasms
    Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Metastatic Breast Cancer
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Breast Cancer
    Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Locally Advanced HER2-Negative Breast Cancer
    Methotrexate or Dactinomycin in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Gestational Trophoblastic Tumor
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Hormone Receptor Positive Malignant Neoplasm of Breast
    Whole-Brain Radiation Therapy With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Tumors Metastatic to Brain
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Fatigue
    A Retrospective Cohort Study of Infusion Reactions Due to Vectibix
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Infusion Reaction
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Anal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Melanoma (Skin)
    S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
    Genetic Study of Young Patients With Colorectal Cancer
    Surgical Oncology of Northeast Georgia
    Gainesville, Georgia 30501
    Colorectal Cancer
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Head and Neck Cancer
    HORIZON-PFT: Pivotal Fracture Trial
    United Osteoporosis Centers (UOC)
    Gainesville, Georgia 30501
    Osteoporosis
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Lung Cancer
    Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Head and Neck Cancer, Oral Complications of Radiation Therapy, Radiation Toxicity
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Pancreatic Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Pancreatic Cancer
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Esophageal Cancer
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Melanoma (Skin)
    Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Esophagus Cancer
    Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Breast Cancer
    Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Breast Cancer
    Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Lung Cancer
    Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Neoplasms, Unknown Primary
    S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Malignant Mesothelioma
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Recurrent Melanoma, Stage IV Melanoma
    Vinflunine Plus Trastuzumab in HER2 Over-Expressing Metastatic Breast Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Breast Neoplasms, Breast Cancer
    Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Small Cell Lung Cancer, Carcinoma, Small Cell
    Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Carcinoma, Small Cell
    5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Rectal Cancer, Cancer of the Rectum, Colorectal Cancer
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Head and Neck Cancer
    Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Neoplasm, Unknown Primary
    Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
    Northeast Georgia Medical Center
    Gainesville, Georgia 30501
    Breast Cancer